EXP MOL MED 润色咨询

EXPERIMENTAL AND MOLECULAR MEDICINE

出版年份：1996 年文章数：1065 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：0.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2024-02-29 bwzhang 来自上海

    审稿速度:6.0
    偏重的研究方向：心脏发育
    经验分享：慢！投稿已经5个多月了！还在外审！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-09-10 ds666888 来自四川省

    偏重的研究方向：肿瘤学
    经验分享：投稿已过20天，记录一下

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-10-30 ms9000001363974617 来自黑龙江省

    审稿速度:3.0
    经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。
    Review #2 received
    Received 29 Oct, 2023
    This content is not available.
    Review #1 received
    Received 24 Oct, 2023
    This content is not available.

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2024-01-26 ms4000000592594051 来自四川省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：单细胞测序
    经验分享：无

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-09-01 ms6000000371699092 来自上海

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：生物大分子;siRNA;基础医学
    经验分享：Stage Start Date
    Under Review 22nd Aug 23 09:29:31
    Author Approved Converted Files 22nd Aug 23 09:29:31
    Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2022-11-16 JayNi

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了
    Stage Start Date
    Under Review 12th Nov 22 00:30:15
    Author Approved Converted Files 12th Nov 22 00:30:15
    Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58

    12

    展开12条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-12-05 ms7000000868707045 来自湖南省

    投稿命中率:25.0
    经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-11-21 xiaoyunzju 来自山东省

    投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-11-02 ms6000001883965747 来自湖北省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：审稿速度太慢

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2190115, encodeId=6c2421901150d, content=审稿速度:6.0<br>偏重的研究方向：心脏发育<br>经验分享：慢！投稿已经5个多月了！还在外审！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4ae5499160, createdName=bwzhang, createdTime=Thu Feb 29 15:31:18 CST 2024, time=2024-02-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2156961, encodeId=68622156961ee, content=偏重的研究方向：肿瘤学<br>经验分享：投稿已过20天，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LXibZVN3MpB1blfiaueaib4iaOtqZg9ZlWgHmqYn3KvVEhfIEicibFxsgJYOj2c9thIBnf6o5mIss0oWYq0z30JnrW4w/132, createdBy=8f7a5200612, createdName=ds666888, createdTime=Sun Sep 10 08:26:45 CST 2023, time=2023-09-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2165659, encodeId=793621656594a, content=审稿速度:3.0<br>经验分享：请问各位学长，学姐 这个的意思是文章内容不符合期刊要拒稿吗。<br>Review #2 received<br>Received 29 Oct, 2023<br>This content is not available.<br>Review #1 received<br>Received 24 Oct, 2023<br>This content is not available., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7186562135, createdName=ms9000001363974617, createdTime=Mon Oct 30 07:38:54 CST 2023, time=2023-10-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2184174, encodeId=7ee321841e410, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：单细胞测序<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=125b6164757, createdName=ms4000000592594051, createdTime=Fri Jan 26 22:16:32 CST 2024, time=2024-01-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2155649, encodeId=4f22215564929, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：生物大分子;siRNA;基础医学<br>经验分享：Stage Start Date<br>Under Review 22nd Aug 23 09:29:31<br>Author Approved Converted Files 22nd Aug 23 09:29:31<br>Preliminary Manuscript Data Submitted 22nd Aug 23 04:02:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af918292843, createdName=ms6000000371699092, createdTime=Fri Sep 01 20:45:42 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2100901, encodeId=8a632100901b2, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：请问这个是送审，还是还在编辑部，还没到编辑手里？有的人说没有AE assigned，有的说收到邮件了<br>Stage Start Date<br>Under Review 12th Nov 22 00:30:15<br>Author Approved Converted Files 12th Nov 22 00:30:15<br>Preliminary Manuscript Data Submitted 11th Nov 22 22:23:58, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Wed Nov 16 16:18:50 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172966, encodeId=257421e296618, content=投稿命中率:25.0<br>经验分享：写信给编辑部，编辑部回应说编辑决定要2-3个月，这个是认真的吗？ Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you.   Sincerely yours,   Heehyun Park, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37278348598, createdName=ms7000000868707045, createdTime=Tue Dec 05 09:03:59 CST 2023, time=2023-12-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2169916, encodeId=2b31216991665, content=投稿快一个月了，杂志系统一直显示under review。 research square 2023.10.25显示Editor assigned;2023.10.30显示为 submission checks complet...This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine.只能等着吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B920FCE6F53899E327DE76521BE8DF0F/100, createdBy=f36d2149028, createdName=xiaoyunzju, createdTime=Tue Nov 21 11:05:21 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2166339, encodeId=278b216633987, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：审稿速度太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bff8308329, createdName=ms6000001883965747, createdTime=Thu Nov 02 18:21:11 CST 2023, time=2023-11-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省)]
    2023-08-29 1581f9a412m 来自贵州省

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：正在投稿

    1

    展开1条回复
共256条页码: 1/26页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分